Suicide · people in the prodromal stage of psychosis
It is very uncertain whether group C other: family treatment changes adverse events: suicide (events) Long‐term (by 24 months) compared with enhanced care (very low certainty).
1 finding from 1 review
Quality of life: clinically important change in quality of life · people in the prodromal stage of psychosis
1 finding from 1 review
Satisfaction with treatment: leaving the study early FACT Long‐term · people in the prodromal stage of psychosis
It is very uncertain whether group C other: family treatment changes satisfaction with treatment: leaving the study early FACT Long‐term compared with enhanced care (very low certainty).
1 finding from 1 review
Prodromal symptoms: transition to psychosis Endpoint data (events) · people in the prodromal stage of psychosis
It is very uncertain whether group C other: integrated treatment changes prodromal symptoms: transition to psychosis Endpoint data (events)… compared with standard treatment (very low certainty).
1 finding from 1 review
Global state: clinically important change in global state · people in the prodromal stage of psychosis
1 finding from 1 review
Mental state SANS total (higher score = worse, scale from 0‐130) · people in the prodromal stage of psychosis
1 finding from 1 review
Behaviour: clinically important change in behaviour · people in the prodromal stage of psychosis
1 finding from 1 review
Adverse effects: at least one serious adverse event · people in the prodromal stage of psychosis
1 finding from 1 review
Global state: antipsychotic prescription Long‐term (events) · people in the prodromal stage of psychosis
Group A: omega‐3 fatty acids may leads to lower global state: antipsychotic prescription Long‐term (events) compared with placebo (low certainty).
1 finding from 1 review
Quality of life: clinically important change in quality of life · people in the prodromal stage of psychosis
1 finding from 1 review
Satisfaction with treatment: leaving the study early Endpoint data (events) · people in the prodromal stage of psychosis
It is very uncertain whether group C other: integrated treatment changes satisfaction with treatment: leaving the study early Endpoint data… compared with standard treatment (very low certainty).
1 finding from 1 review
Intervention not reported
Tardive dyskinesia: Not improved to a clinically important extent · patients with antipsychotic‐induced TD
The intervention may leads to lower tardive dyskinesia: Not improved to a clinically important extent (low certainty).
1 finding from 1 review
Intervention not reported
Tardive dyskinesia: Deterioration of symptoms · patients with antipsychotic‐induced TD
It is very uncertain whether the intervention changes tardive dyskinesia: Deterioration of symptoms (very low certainty).
1 finding from 1 review
Intervention not reported
Adverse events · patients with antipsychotic‐induced TD
It is very uncertain whether the intervention changes adverse events (very low certainty).
1 finding from 1 review
Intervention not reported
Mental state: Deterioration · patients with antipsychotic‐induced TD
It is very uncertain whether the intervention changes mental state: Deterioration (very low certainty).
1 finding from 1 review
Intervention not reported
Acceptability of treatment: Leaving the study early · patients with antipsychotic‐induced TD
It is very uncertain whether the intervention changes acceptability of treatment: Leaving the study early (very low certainty).
1 finding from 1 review
Intervention not reported
Social confidence, social inclusion, social networks, or personalised quality of life measures · patients with antipsychotic‐induced TD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Tardive dyskinesia: No clinically important improvement · patients with antipsychotic‐induced tardive dyskinesia
1 finding from 1 review
Adverse effect: any adverse effects · chronic schizophrenia patients with antipsychotic‐induced tardive dyskinesia
It is very uncertain whether anticholinergic medication changes adverse effect: any adverse effects compared with other treatments (very low certainty).
1 finding from 1 review
Leaving the study early · chronic schizophrenia patients with antipsychotic‐induced tardive dyskinesia
It is very uncertain whether anticholinergic medication changes acceptability of the treatment: leaving the study early compared with other treatments (very low certainty).
1 finding from 1 review